SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-023053
Filing Date
2022-09-26
Accepted
2022-09-26 16:02:49
Documents
13
Period of Report
2022-09-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bioli20220923_8k.htm   iXBRL 8-K 25051
  Complete submission text file 0001437749-22-023053.txt   157518

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA blfs-20220920.xsd EX-101.SCH 3602
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE blfs-20220920_def.xml EX-101.DEF 11533
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE blfs-20220920_lab.xml EX-101.LAB 15415
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE blfs-20220920_pre.xml EX-101.PRE 11689
7 EXTRACTED XBRL INSTANCE DOCUMENT bioli20220923_8k_htm.xml XML 2580
Mailing Address 3303 MONTE VILLA PARKWAY SUITE 310 BOTHELL WA 98021
Business Address 3303 MONTE VILLA PARKWAY SUITE 310 BOTHELL WA 98021 4254011400
BIOLIFE SOLUTIONS INC (Filer) CIK: 0000834365 (see all company filings)

IRS No.: 943076866 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36362 | Film No.: 221265663
SIC: 3845 Electromedical & Electrotherapeutic Apparatus